NRx Pharmaceuticals underwriters exercise overallotment, issue 750K shares at $0.30

NRX Pharmaceuticals, Inc.

Underwriters exercised overallotment option for 750,000 shares at $0.30/share, closed March 6, 2024.
Option shares are part of the underwritten public offering announced Feb 27, 2024, with EF Hutton as lead underwriter.
Gross proceeds from the option exercise total approximately $225,000 before underwriting discounts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.